Aug 20, 2019
Biohacking: Why I’ll live to be 180 years old
Posted by Paul Battista in categories: bioengineering, life extension
From computer hacking to biohacking, Dave Asprey has embarked on a quest to reverse the aging process.
From computer hacking to biohacking, Dave Asprey has embarked on a quest to reverse the aging process.
In the 2015 movie “Chappie”, which is set in the near future, automated robots comprise a mechanised police force. An encounter between two rival criminal gangs severely damages the law enforcing robot (Agent 22). His creator Deon recommends dismantling and recycling the damaged police droids. However, criminals kidnap Deon and force him to upload human consciousness into the damaged robot to train it to rob banks. Chappie becomes the first robot with the human mind who can think and feel like a human. Later, in the movie when his creator Deon is dying, it’s Chappie’s turn to upload Deon’s consciousness into a spare robot through a neural helmet. Similarly, in the “Avatar” a 2009 Hollywood science fiction, a character in the film by name Grace connects with Eiwa, the collective consciousness of the planet and transfers her mind to her Avatar body, while another character Jake transfers his mind to his Avatar body rendering his human body lifeless.
Mind uploading is a process by which we relocate the mind, an assemblage of memories, personality, and attributes of a specific individual, from its original biological brain to an artificial computational substrate. Mind uploading is a central conceptual feature of many science fiction novels and films. For instance, Hanson’s book titled “The Age of Em: Work, Love and Life when Robots Rule the Earth” is a 2016 nonfiction book which explores the implications of a future world when researchers have learned to copy humans onto computers, creating “ems,” or emulated people, who quickly come to outnumber the real ones.
UK company raises $100m to find fountain of ‘eternal youth’ by cheating death and REVERSING ageing with new technology…
The firm announced a total investment of $10 million from its founders and a further $10 million each from core investors.
It seems that billionaire biotech investor Jim Mellon is the flavor of the month as he continues the drive to create a rejuvenation biotech industry. Jim and his colleagues at Juvenescence have announced that they have secured another $100M for the company, and it will be used to invest and support the growth of promising biotech companies working in this field.
Juvenescence has a varied investment portfolio of companies that range in potential usefulness, depending on your point of view, and they mostly favor the more traditional small molecule drug approach. There are a few companies that are of particular interest.
https://youtube.com/watch?v=BPKHHQFI-WM
People say, well, but we’re going to stop being human if we merge with machines. No, that is what it means to be human.
Dr. Kurtzweil, I would like to ask you. You have made hundreds of predictions out of which many already have come true, and with no doubt many more will come through. But if you would have to single out your three most important predictions for the upcoming decade, what would they be?
Continue reading “Ray Kurzweil: Enhanced Longevity by 2030” »
In 2006, scientists discovered a way to “reprogram” mature cells—adult skin cells, for example—into stem cells that could, in principle, give rise to any tissue or organ in the body. Many assumed it was only a matter of time until this groundbreaking technique found its way into the clinic and ushered in a regenerative medicine revolution.
Because the same patient would be both the donor and the recipient of cells derived from these so-called induced pluripotent stem cells (iPSCs), these cells would be seen as “self” by the immune system, the thinking went, and not subject to the problems of rejection that plague conventional transplants.
But iPSCs haven’t emerged as the cure-all that was originally envisioned, due to unforeseen setbacks, including the surprising preclinical finding that iPSC-derived cell transplants are often rejected, even after being reintroduced into the organism the cells were sourced from.
Each Cyclops had a single eye because, legend has it, the mythical giants traded the other one with the god Hades in return for the ability to see into the future. But Hades tricked them: the only vision the Cyclopes were shown was the day they would die. They carried this knowledge through their lives as a burden—the unending torture of being forewarned and yet having no ability to do anything about it.
Since ancient times, aging has been viewed as simply inevitable, unstoppable, nature’s way. “Natural causes” have long been blamed for deaths among the old, even if they died of a recognized pathological condition. The medical writer Galen argued back in the second century AD that aging is a natural process.
His view, the acceptance that one can die simply of old age, has dominated ever since. We think of aging as the accumulation of all the other conditions that get more common as we get older—cancer, dementia, physical frailty. All that tells us, though, is that we’re going to sicken and die; it doesn’t give us a way to change it. We don’t have much more control over our destiny than a Cyclops.
Today, we’re offering another discussion from Ending Age-Related Diseases 2019, our highly successful two-day conference that featured talks from leading researchers and investors, bringing them together to discuss the future of aging and rejuvenation biotechnology.
Today, we’re offering another talk from Ending Age-Related Diseases 2019, our highly successful two-day conference that featured talks from leading researchers and investors, bringing them together to discuss the future of aging and rejuvenation biotechnology.
Continue reading “Ronald Kohanski at Ending Age-Related Diseases 2019” »